News From the American Society of Hematology (ASH) 2018 Annual Meeting

 

Look for new and expanded programs added day by day.

 

Email this program

Get Link

AML

ASH 2018 AML Treatment and Research Updates From an Expert Roundtable

Patient Power founders Andrew and Esther Schorr are joined by a panel of AML experts to discuss highlights from the 2018 American Society of Hematology (ASH) annual meeting in what they call an “AML treatment revolution.” Tune in to find out the latest news.

Published:

CLL

CLL Access to Care: How Patients Can Get Access to the Latest Treatments

Patient Power’s Andrew Schorr is joined by experts to discuss access issues for patients. Dr. Gwen L. Nichols and Dr. Larry Saltzman of The Leukemia & Lymphoma Society (LLS), Hildy Dillon from Cancer Support Community, and Dr. Kathleen Toomy of Regional Cancer Care Associates each share insights on to how patients can navigate access issues.

Published:

ASH CLL News 2018: Tools for Staying Up-to-Date on Research

At the recent 2018 American Society of Hematology (ASH) conference in San Diego, Patient Power host and CLL patient advocate, Lee Swanson interviews Dr. Anthony Mato to review key research developments.

Published:

ASH CLL News 2018: How Could Research Results Impact You?

At the 2018 American Society of Hematology (ASH) conference in San Diego, Patient Power host and CLL patient advocate, Lee Swanson, is joined by Dr. Kerry Rogers, from The Ohio State University Medical Center.

Published:

ASH 2018 Annual Meeting: A Patient Perspective on CLL Treatment Developments

From the 2018 American Society of Hematology (ASH) annual meeting in San Diego, CA, CLL patient Lee Swanson joins Patient Power to discuss the impact of research, education and finding a specialist on a person’s cancer care. Tune in to find out more about ASH 2018 from a patient’s perspective.

Published:

CLL ASH News 2018: Staying Informed About Clinical Trials

At the 2018 American Society of Hematology (ASH) conference in San Diego, Patient Power host and CLL patient advocate, Lee Swanson, interviews Dr. Adrian Wiestner, Senior Investigator, Laboratory of Lymphoid Malignancies at the National Heart, Lung, and Blood Institute (NHLBI).

Published:

A CLL Expert Roundtable: Treatment News From ASH 2018

On-site in San Diego, CA at the 2018 American Society of Hematology (ASH) annual meeting, a panel of CLL experts joined Patient Power to share breakthroughs in treatment research announced at the conference and explore emerging approaches to therapy. Watch now to find out the latest CLL news.

Published:

ASH 2018 Daily Wrap: CLL News

On location in San Diego, CA, Patient Power founders Andrew and Esther Schorr are joined by a panel of experts to discuss research developments announced at ASH 2018. Watch day three of Patient Power’s daily wrap to hear the latest blood cancer-related treatment news.

Published:

CML

CML News From ASH: Patient Advocate Perspective

As part of our coverage of the 2018 American Society of Hematology (ASH) annual meeting in San Diego, Jan Geissler, a patient advocate and director of the European Patients Academy on Therapeutic Innovation, joined Patient Power to share his perspective on the latest news in chronic myeloid leukemia (CML).

Published:

Hodgkin Lymphoma

Expert Updates in Hodgkin Lymphoma From ASH 2018

Dr. Ramchandren joins Lee Swanson to discuss the changing treatment for Hodgkin lymphoma patients. From management of side effects to new line treatments, they discuss how patients can best discuss these changes with their doctors.

Published:

Hodgkin Lymphoma News From ASH 2018: Updates From Leading Experts

As part of Patient Power’s coverage from the 2018 American Society of Hematology (ASH) annual meeting, a panel of experts in Hodgkin lymphoma , including Dr. Andrew Evens, Dr. Joshua Brody, as well as Andrew Schorr, gathered to discuss the latest news and developments related to research and treatment of Hodgkin lymphoma.

Published:

Mantle Cell Lymphoma

Mantle Cell Lymphoma News From ASH 2018: Treatment Research Updates

On-site in San Diego, CA at the 2018 American Society of Hematology (ASH) annual meeting, Patient Power founder Andrew Schorr is joined by renowned expert Dr. Peter Martin to discuss highlights in mantle cell lymphoma treatment news.

Published:

An Evolving Treatment Landscape: Mantle Cell Lymphoma Treatment and Research News From an Expert

Noted expert Dr. Stephen Douglas Smith joined Patient Power to share promising advances being made in therapies for mantle cell lymphoma. Watch now to stay up-to-date with the latest treatment and research news.

Published:

MPNs

MPN Headlines From ASH 2018 With Dr. Casey O’Connell

As part of our coverage of the 2018 American Society of Hematology (ASH) Annual Meeting, Dr. Casey L. O’Connell joined Patient Power to comment on the latest headlines in myeloproliferative neoplasms (MPNs).

Published:

Updates From ASH 2018: The Latest on Interferon Therapy in MPNs

MPN experts, Dr. Srdan Verstovsek and Dr. Abdulraheem Yacoub provide an update from ASH 2018, including the latest in interferon research for the treatment of polycythemia vera (PV).

Published:

MPN News From ASH 2018: Perspectives From Leading Experts

As part of Patient Power’s coverage from the 2018 American Society of Hematology (ASH) annual meeting, a panel of experts in myeloproliferative neoplasms (MPNs), including Dr. Srdan Verstovsek, Dr. Abdulraheem Yacoub and Lindsey Lyle, as well as Andrew Schorr, gathered to discuss the latest news and developments related to research and treatment of MPNs.

Published:

ASH 2018 Daily Wrap: MPN News

On location in San Diego, CA, Patient Power founders Andrew and Esther Schorr are joined by a panel of experts to discuss research developments announced at ASH 2018. Watch day one of Patient Power’s daily wrap to hear the latest blood cancer-related treatment news.

Published:

Myeloma

News From ASH 2018: A Multitude of Options In Myeloma

Dr. Robert Orlowski from The University of Texas MD Anderson Cancer Center weighs in on the flurry of myeloma news out of the ASH 2018 meeting.

Published:

Myeloma News From ASH 2018: Updates on CAR-T Therapy, Antibody Drug Conjugates and Maintenance Strategies

On-site in San Diego, CA, Patient Power founder Esther Schorr is joined by leading myeloma expert Dr. Amrita Krishnan to discuss highlights from the 2018 American Society of Hematology (ASH) annual meeting. Dr. Krishnan explains what exciting research advances were made and the “top three” in treatment development for myeloma patients.

Published:

ASH 2018 Daily Wrap: Myeloma News

In day two of Patient Power’s daily wrap-up from the 2018 American Society of Hematology (ASH) meeting in San Diego, Patient Power founders Andrew and Esther Schorr are joined by a panel of leading experts to discuss impressive treatment advances and important headlines in clinical research. Watch now to find out the latest news in cancer care.

Published:

Non-Hodgkin Lymphoma

Follicular Lymphoma News at ASH 2018: An Update From Dr. Peter Martin

From the 2018 American Society of Hematology (ASH) annual meeting in San Diego, CA, Patient Power founder Andrew Schorr is joined by leading expert Dr. Peter Martin to discuss follicular lymphoma treatment news announced at the conference. Watch now to stay up-to-date with the latest research.

Published:

Updates From ASH 2018 Peripheral T-Cell Lymphoma With Dr. Horwitz

Dr. Steven Horwitz joins Lee Swanson to discuss new approvals and advancements made in peripheral T-cell lymphoma at ASH 2018. Dr. Steven Horwitz has been instrumental in these studies leading to approval for new treatments.

Published:

Advertisement
Unisciti alla nostra comunità Registrati per eventi Leggi il nostro ultimo blog
Advertisement

Page last updated on December 17, 2018